ICU Medical (ICUI)
(Delayed Data from NSDQ)
$94.84 USD
+0.31 (0.33%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $94.89 +0.05 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$94.84 USD
+0.31 (0.33%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $94.89 +0.05 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
B Value D Growth D Momentum C VGM
Zacks News
Strength Seen in PetIQ (PETQ): Can Its 9.3% Jump Turn into More Strength?
by Zacks Equity Research
PetIQ (PETQ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
New Strong Sell Stocks for September 8th
by Zacks Equity Research
CIEN, CYH and ICUI have been added to the Zacks Rank #5 (Strong Sell) List on September 8, 2022.
New Strong Sell Stocks for August 11th
by Zacks Equity Research
CBAN, ICUI, and NVDA have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2022.
ICU Medical (ICUI) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of -18.93% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical (ICUI) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 1.68% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions
by Zacks Equity Research
Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions have been highlighted in this Screen of the Week article.
ICU Medical (ICUI) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does ICU Medical (ICUI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Hepion Pharmaceuticals, Inc. (HEPA) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Hepion Pharmaceuticals, Inc. (HEPA) and ICU Medical (ICUI) have performed compared to their sector so far this year.
Buy These 4 Low-Beta Stocks to Combat the Choppy Market
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), OP Bancorp (OPBK), ICU Medical (ICUI) and Pangaea Logistics (PANL) are well poised to gain.
Is ICU Medical (ICUI) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
ICU Medical (ICUI) possesses solid growth attributes, which could help it handily outperform the market.
Is Aptinyx Inc. (APTX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Aptinyx Inc. (APTX) and ICU Medical (ICUI) have performed compared to their sector so far this year.
Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice
by Zacks Equity Research
ICU Medical (ICUI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ICU Medical (ICUI) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 11.66% and 6.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -64.29% and 5.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons Why ICU Medical (ICUI) Is a Great Growth Stock
by Zacks Equity Research
ICU Medical (ICUI) possesses solid growth attributes, which could help it handily outperform the market.
ICU Medical (ICUI) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 15.64% and 6.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company News for Sep 9, 2021
by Zacks Equity Research
Companies In The News Are: COIN, TSLA, SPB, ICUI
ICU Medical (ICUI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 14.63% and 5.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: ICU Medical (ICUI) Q2 Earnings Expected to Decline
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 5.88% and 4.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
ICU Medical (ICUI) delivered earnings and revenue surprises of 48.44% and 13.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: ICU Medical (ICUI) Q3 Earnings Expected to Decline
by Zacks Equity Research
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.